Cargando…

Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis

BACKGROUND: Kaposi sarcoma (KS) is a multicentric tumor caused by Kaposi sarcoma herpesvirus (KSHV) that leads to morbidity and mortality among people with HIV worldwide. KS commonly involves the skin but can occur in the gastrointestinal tract (GI) in severe cases. METHODS: RNA sequencing was used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramaswami, Ramya, Tagawa, Takanobu, Mahesh, Guruswamy, Serquina, Anna, Koparde, Vishal, Lurain, Kathryn, Dremel, Sarah, Li, Xiaofan, Mungale, Ameera, Beran, Alex, Ohler, Zoe Weaver, Bassel, Laura, Warner, Andrew, Mangusan, Ralph, Widell, Anaida, Ekwede, Irene, Krug, Laurie T., Uldrick, Thomas S., Yarchoan, Robert, Ziegelbauer, Joseph M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517594/ https://www.ncbi.nlm.nih.gov/pubmed/37740179 http://dx.doi.org/10.1186/s12967-023-04517-5

Ejemplares similares

Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma
por: Lurain, Kathryn, et al.
Publicado: (2021)

Characterizing Expression and Regulation of Gamma-Herpesviral Circular RNAs
por: Tagawa, Takanobu, et al.
Publicado: (2021)

A virus-induced circular RNA maintains latent infection of Kaposi’s sarcoma herpesvirus
por: Tagawa, Takanobu, et al.
Publicado: (2023)

25-Hydroxycholesterol Inhibits Kaposi’s Sarcoma Herpesvirus and Epstein-Barr Virus Infections and Activates Inflammatory Cytokine Responses
por: Serquiña, Anna K. P., et al.
Publicado: (2021)

Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma
por: Lurain, Kathryn, et al.
Publicado: (2022)

Interferon induced circRNAs escape herpesvirus host shutoff and suppress lytic infection
por: Dremel, Sarah E., et al.
Publicado: (2023)

Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA
por: Gruffaz, Marion, et al.
Publicado: (2020)

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2012)

Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2017)

CRISPR Interference Efficiently Silences Latent and Lytic Viral Genes in Kaposi’s Sarcoma-Associated Herpesvirus-Infected Cells
por: Brackett, Kevin, et al.
Publicado: (2021)

Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer
por: Odeny, Thomas A, et al.
Publicado: (2022)

How herpesviruses pass on their genomes
por: Serquiña, Anna K., et al.
Publicado: (2017)

RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature
por: Viollet, Coralie, et al.
Publicado: (2017)

Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease
por: Shrestha, Prabha, et al.
Publicado: (2023)

Evaluation of Non-Invasive Multispectral Imaging as a Tool for Measuring the Effect of Systemic Therapy in Kaposi Sarcoma
por: Kainerstorfer, Jana M., et al.
Publicado: (2013)

Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection
por: Serquiña, Anna K. P., et al.
Publicado: (2017)

Pomalidomide increases immune surface marker expression and immune recognition of oncovirus-infected cells
por: Davis, David A., et al.
Publicado: (2018)

Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV
por: Uldrick, Thomas S, et al.
Publicado: (2012)

A Phase Ib Study of Sorafenib (BAY 43‐9006) in Patients with Kaposi Sarcoma
por: Uldrick, Thomas S., et al.
Publicado: (2017)

Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
por: Uldrick, Thomas, et al.
Publicado: (2010)

Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions
por: Marshall, Vickie A., et al.
Publicado: (2018)

[(18)F]-fluoro-D-deoxyglucose positron emission tomography findings in Kaposi sarcoma herpes virus associated multicentric Castleman disease: correlation with clinical, inflammatory, and virologic parameters
por: Polizzotto, Mark N, et al.
Publicado: (2012)

Increasing incidence of Kaposi's sarcoma in black South Africans In Kwazulu-Natal, South Africa (1983 to 2006)
por: Uldrick, TS, et al.
Publicado: (2009)

Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma
por: Burbelo, Peter D, et al.
Publicado: (2010)

KSHV MicroRNAs Repress Tropomyosin 1 and Increase Anchorage-Independent Growth and Endothelial Tube Formation
por: Kieffer-Kwon, Philippe, et al.
Publicado: (2015)

Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013
por: Royse, Kathryn E., et al.
Publicado: (2017)

Health-Related Quality of Life in Patients Treated With Antiretroviral Therapy Only Versus Chemotherapy and Antiretroviral Therapy for HIV-Associated Kaposi Sarcoma: A Randomized Control Trial
por: Shaik, Fahmida, et al.
Publicado: (2018)

Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia
por: Velasco, P, et al.
Publicado: (2009)

HAART and response to therapy improve quality of life (QOL) of African patients with advanced HIV-associated Kaposi’s sarcoma (HIV-KS): a prospective analysis of QOL in the KAART trial
por: Mosam, Anisa, et al.
Publicado: (2010)

Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti–PD1/PDL1 Clinical Trials
por: Reuss, Joshua E., et al.
Publicado: (2020)

Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770
por: Uldrick, TS, et al.
Publicado: (2009)

Nonepidemic Kaposi sarcoma: A recently proposed category
por: Hinojosa, Tiffany, et al.
Publicado: (2017)

The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and \chemotherapy in treatment-naïve patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa
por: Mosam, A, et al.
Publicado: (2010)

Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide
por: Davis, David A., et al.
Publicado: (2017)

Kaposi's sarcoma.
por: Dalgleish, A. G.
Publicado: (1991)

Kaposi's Disease
por: Stonham, Franklyn V., et al.
Publicado: (1941)

Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells
por: Viollet, Coralie, et al.
Publicado: (2015)

A novel simplified method for managing inadvertent tube cut during aurolab aqueous drainage implant surgery for refractory glaucoma
por: Mungale, Sachin, et al.
Publicado: (2019)

Transcriptional mapping of the macaque retina and RPE-choroid reveals conserved inter-tissue transcription drivers and signaling pathways
por: Mungale, Ameera, et al.
Publicado: (2022)

Sarcoma de Kaposi /
por: Jiménez Jiménez, Leticia
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_m0rhd7s9c7ll6cn9f7lo34ip45